4.8 Review

Understanding Dopaminergic Cell Death Pathways in Parkinson Disease

Journal

NEURON
Volume 90, Issue 4, Pages 675-691

Publisher

CELL PRESS
DOI: 10.1016/j.neuron.2016.03.038

Keywords

-

Categories

Funding

  1. Investissements d'avenir [ANR-10-IAIHU-06, ANR-11-INBS-0011-NeurATRIS]
  2. association France Parkinson
  3. ParKemoS [ANR-2010-BLAN-1418-01]
  4. X-Protect [ANR-12-EMMA-0016-01]
  5. Ire1-PD [ANR-13-ISV4-0003-03]
  6. ParkSTRIM [ANR-13-BSV1-0013-01]
  7. JPND CrossSeeds [ANR-14-JPCD-0005-02]
  8. JPND SYNaction [ANR-15-JPWG-0012-04]
  9. Agence Nationale de la Recherche (ANR) [ANR-15-JPWG-0012] Funding Source: Agence Nationale de la Recherche (ANR)

Ask authors/readers for more resources

Parkinson disease (PD) is a multifactorial neurodegenerative disorder, the etiology of which remains largely unknown. Progressive impairment of voluntary motor control, which represents the primary clinical feature of the disease, is caused by a loss of midbrain substantia nigra dopamine (DA) neurons. We present here a synthetic overview of cell-autonomous mechanisms that are likely to participate in DA cell death in both sporadic and inherited forms of the disease. In particular, we describe how damage to vulnerable DA neurons may arise from cellular disturbances produced by protein misfolding and aggregation, disruption of autophagic catabolism, endoplasmic reticulum (ER) stress, mitochondrial dysfunction, or loss of calcium homeostasis. Where pertinent, we show how these mechanisms may mutually cooperate to promote neuronal death.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available